Centre caps trade margins on non-scheduled cancer drugs at 30%, expects ₹2,500 crore annual savings for patients

The government expects to reduce prices of the non-scheduled cancer drugs by up to 70% through the move and help patients save ₹2,500 crore annually.
Read the full story on Hindustan Times Opens hindustantimes.com in a new tab
This is a short summary of a story published by Hindustan Times, shown with a link to the original. The full story, photo and reporting belong to Hindustan Times.










